NCT02336425 Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma Status TERMINATED Phase PHASE2
NCT02334553 Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma Status COMPLETED Phase PHASE2
NCT02333630 Randomized Prospective Trial of a Mobile Health Application for Asthma Self-Management Status COMPLETED Phase NA
NCT02327897 NHALES (Natural History of Asthma With Longitudinal Environmental Sampling) Status RECRUITING Phase N/A
NCT02322788 Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3 Status COMPLETED Phase PHASE3
NCT02322775 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma Status COMPLETED Phase PHASE3
NCT02319967 Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes Status COMPLETED Phase NA
NCT02308098 To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product Status COMPLETED Phase PHASE3
NCT02302040 Applying Interactive Mobile Health to Asthma Care in Teens (AIM2ACT) Status COMPLETED Phase NA
NCT02301975 An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma Status COMPLETED Phase PHASE3
NCT02298205 Asthma Symptom Based Adjustment of Inhaled Steroid Therapy in African American Children Status COMPLETED Phase PHASE4
NCT02296489 An Association Between Asthma Severity and Capnography Parameters Status COMPLETED Phase N/A
NCT02296411 Efficacy of LAMA Added to ICS in Treatment of Asthma (ELITRA) Status COMPLETED Phase PHASE2
NCT02294279 The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms Status COMPLETED Phase PHASE4